These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20580255

  • 1. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
    Tsukamoto Y, Takizawa S, Takahashi W, Mase H, Miyachi H, Miyata T, Takagi S.
    J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
    [Abstract] [Full Text] [Related]

  • 2. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
    [Abstract] [Full Text] [Related]

  • 3. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K, Yamada K, Yamatoku M, Sakurai K, Takaishi S, Kato B, Hirayama T, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
    [Abstract] [Full Text] [Related]

  • 4. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
    Shinohara Y, Saito I, Kobayashi S, Uchiyama S.
    Cerebrovasc Dis; 2009 Feb; 27(5):485-92. PubMed ID: 19321945
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chronic kidney disease in patients with ischemic stroke.
    Tsukamoto Y, Takahashi W, Takizawa S, Kawada S, Takagi S.
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):547-50. PubMed ID: 21295995
    [Abstract] [Full Text] [Related]

  • 7. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease.
    Ovbiagele B, Sanossian N, Liebeskind DS, Kim D, Ali LK, Pineda S, Saver JL.
    Cerebrovasc Dis; 2009 Oct; 28(6):582-8. PubMed ID: 19844098
    [Abstract] [Full Text] [Related]

  • 8. Pulse pressure and progression of chronic kidney disease.
    Arulkumaran N, Diwakar R, Tahir Z, Mohamed M, Kaski JC, Banerjee D.
    J Nephrol; 2010 Oct; 23(2):189-93. PubMed ID: 20119928
    [Abstract] [Full Text] [Related]

  • 9. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
    Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M.
    J Neurol Sci; 2004 Jun 15; 221(1-2):11-7. PubMed ID: 15178207
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure.
    Takagi A, Iwama Y, Yamada A, Aihara K, Daida H.
    J Cardiol; 2010 May 15; 55(3):317-21. PubMed ID: 20350524
    [Abstract] [Full Text] [Related]

  • 12. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.
    Tsagalis G, Akrivos T, Alevizaki M, Manios E, Stamatellopoulos K, Laggouranis A, Vemmos KN.
    Nephrol Dial Transplant; 2009 Jan 15; 24(1):194-200. PubMed ID: 18728156
    [Abstract] [Full Text] [Related]

  • 13. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N, Yamaguchi T, Awano H, Matsuda H.
    J Stroke Cerebrovasc Dis; 2018 May 15; 27(5):1302-1310. PubMed ID: 29373227
    [Abstract] [Full Text] [Related]

  • 14. Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke.
    Lee JG, Lee KB, Jang IM, Roh H, Ahn MY, Woo HY, Hwang HW.
    Cerebrovasc Dis; 2013 May 15; 35(1):53-9. PubMed ID: 23428997
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria and clinical outcomes after ischemic stroke.
    Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T, FSR Investigators.
    Neurology; 2012 Jun 12; 78(24):1909-15. PubMed ID: 22592359
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Jun 12; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
    Bakken AM, Protack CD, Saad WE, Hart JP, Rhodes JM, Waldman DL, Davies MG.
    Ann Vasc Surg; 2009 Jun 12; 23(5):560-8. PubMed ID: 19128934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.